RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy
Clinical trial NCT02452970 · TERMINATED
Trial details
- NCT number
- NCT02452970
- Sponsor
- EpicentRx, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-16
- Primary completion
- 2016-05-10
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.